An immunomodulating medicine for specified blood cancers or myelodysplastic syndromes, sometimes with other treatments.
Profile scope: Lenalidomide. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Bowel symptoms, fatigue, dizziness, taste changes, tingling, body discomfort, or skin dryness may occur.
Serious risks and warning signs
Severe birth defects or fetal death, blood-cell suppression, and dangerous clots are major warnings. Pregnancy prevention applies to patients and partners as directed. Serious skin reactions, infection, bleeding, liver or kidney changes, and additional cancers also require surveillance.
A question for your healthcare team
Can we review pregnancy-program requirements, clot prevention, blood monitoring, donation restrictions, and safe handling before treatment?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.